More thorough investigations will be required to discover the probable contribution of IL-6 promoter polymorphisms to HCC progression in HCV-infected individuals, keeping in view the future application of SNPs as biomarkers for onset and prediction of the prognosis of viral-induced chronic infection, as well as to explore better treatment options. The gene discussed is IL6; the disease is hepatocellular carcinoma.